These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
439 related articles for article (PubMed ID: 28763304)
1. Chronic inflammatory demyelinating polyneuropathy. Lewis RA Curr Opin Neurol; 2017 Oct; 30(5):508-512. PubMed ID: 28763304 [TBL] [Abstract][Full Text] [Related]
2. Chronic inflammatory demyelinating polyneuropathy: considerations for diagnosis, management, and population health. Ryan M; Ryan SJ Am J Manag Care; 2018 Sep; 24(17 Suppl):S371-S379. PubMed ID: 30312032 [TBL] [Abstract][Full Text] [Related]
3. Progress in diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy. Bunschoten C; Jacobs BC; Van den Bergh PYK; Cornblath DR; van Doorn PA Lancet Neurol; 2019 Aug; 18(8):784-794. PubMed ID: 31076244 [TBL] [Abstract][Full Text] [Related]
13. Different electrophysiological profiles and treatment response in 'typical' and 'atypical' chronic inflammatory demyelinating polyneuropathy. Kuwabara S; Isose S; Mori M; Mitsuma S; Sawai S; Beppu M; Sekiguchi Y; Misawa S J Neurol Neurosurg Psychiatry; 2015 Oct; 86(10):1054-9. PubMed ID: 25424435 [TBL] [Abstract][Full Text] [Related]
14. ELectron microscopic abnormality and therapeutic efficacy in chronic inflammatory demyelinating polyneuropathy with anti-neurofascin155 immunoglobulin G4 antibody. Kuwahara M; Suzuki H; Oka N; Ogata H; Yanagimoto S; Sadakane S; Fukumoto Y; Yamana M; Yuhara Y; Yoshikawa K; Morikawa M; Kawai S; Okazaki M; Tsujimoto T; Kira JI; Kusunoki S Muscle Nerve; 2018 Mar; 57(3):498-502. PubMed ID: 28796305 [TBL] [Abstract][Full Text] [Related]
15. Current concepts and controversy in chronic inflammatory demyelinating polyneuropathy. Saperstein DS; Barohn RJ Curr Neurol Neurosci Rep; 2003 Jan; 3(1):57-63. PubMed ID: 12507413 [TBL] [Abstract][Full Text] [Related]
16. Investigations and treatment of chronic inflammatory demyelinating polyradiculoneuropathy and other inflammatory demyelinating polyneuropathies. Tracy JA; Dyck PJ Curr Opin Neurol; 2010 Jun; 23(3):242-8. PubMed ID: 20389243 [TBL] [Abstract][Full Text] [Related]
17. CIDP and other inflammatory neuropathies in diabetes - diagnosis and management. Rajabally YA; Stettner M; Kieseier BC; Hartung HP; Malik RA Nat Rev Neurol; 2017 Oct; 13(10):599-611. PubMed ID: 28914883 [TBL] [Abstract][Full Text] [Related]
19. Are the treatments for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) effective and safe? - A Cochrane Overview summary with commentary. Oaklander AL; Gimigliano F NeuroRehabilitation; 2019; 44(4):609-612. PubMed ID: 31256085 [TBL] [Abstract][Full Text] [Related]
20. Treatment of chronic immune-mediated neuropathies: chronic inflammatory demyelinating polyradiculoneuropathy, multifocal motor neuropathy, and the Lewis-Sumner syndrome. Sederholm BH Semin Neurol; 2010 Sep; 30(4):443-56. PubMed ID: 20941678 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]